Author

Yong-Liang Zheng

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Anti-tumor activity of valproic acid in EBV-positive Burkitt lymphoma via PFN2-associated PI3K/AKT pathway repression

VPA exerts potent anti-tumor activity against EBV-positive BL in vitro and in multiple xenograft models, associated with PFN2 downregulation and suppressed PI3K/AKT signaling.

Yong-Liang Zheng, Yu-Xiu Yang, Shou-Hua Zhang et al. · Frontiers in Pharmacology · 0 citations

Open access Aug 2026

Integrative multi-omics profiling reveals an association between lipid metabolism dysregulation and bortezomib-induced cerebral hemorrhage in zebrafish

Bortezomib (BTZ), a first-generation proteasome inhibitor, serves as a cornerstone chemotherapeutic agent for Multiple Myeloma (MM), with its clinical application in oncology expanding rapidly in recent years. Using vascular-specific transgenic zebrafish models, we systematically evaluated BTZ-induced toxicity at 4–5 m...

Yu-Lian Li, Si Dong, Hao Cheng et al. · Fluids and Barriers of the C... · 0 citations